GRANULOCYTOPENIA FOLLOWING THE ADMINISTRATION OF SULPHANILAMIDE COMPOUNDS
- 5 November 1938
- journal article
- Published by Elsevier in The Lancet
- Vol. 232 (6010) , 1044-1047
- https://doi.org/10.1016/s0140-6736(00)41782-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of Puerperal Sepsis by Prontosil and Allied CompoundsBJOG: An International Journal of Obstetrics and Gynaecology, 1938
- Granulocytopenia and hyperleucocytosis following sulfanilamide therapyThe Journal of Pediatrics, 1938
- Control of Sulphanilamide TherapyBMJ, 1938
- FATAL GRANULOCYTOPENIA FOLLOWING SULFANILAMIDE THERAPYJAMA, 1938
- THE LEUKOCYTE RESPONSE TO SULFANILAMIDE THERAPYJAMA, 1938
- ANÆMIA AND AGRANULOCYTOSIS DURING SULPHANILAMIDE THERAPYThe Lancet, 1937
- THE CLINICAL USE OF SULPHANILAMIDE AND ITS DERIVATIVES IN THE TREATMENT OF INFECTIOUS DISEASESAnnals of Internal Medicine, 1937
- Report on the use of sulfanilamide at the Children's Hospital of MichiganThe Journal of Pediatrics, 1937
- Report on the use of sulfanilamide and its derivatives at the Children's Hospital of CincinnatiThe Journal of Pediatrics, 1937
- DEATH FROM AGRANULOCYTOSIS AFTER TREATMENT WITH PRONTOSIL FLAVUMThe Lancet, 1937